Nuvem Expands Leadership to Advance Pharmacy Service Model
Nuvem Expands Leadership Team to Accelerate Pharmacy Service Model for Community Health Providers Strengthened product, technology, and finance leadership positions company to scale mission-driven pharmacy solutions Nuvem, a leading tech-enabled…
Sensory Cloud Reports Positive Phase 2a Results in Chronic Cough Study
Sensory Cloud Reports Encouraging Phase 2a REACH Trial Results for Novel Aerosol Therapy in Refractory Chronic Cough Sensory Cloud Inc., a clinical-stage biopharmaceutical company developing first-in-class therapies targeting mechano-sensitive ion…
Scipher Medicine Unveils AI Platform to Predict Clinical Trial Failure
Scipher Medicine Launches ClinicalTrialRank.com: AI-Powered Platform to Predict Clinical Trial Failure and Transform Drug Development Strategy Scipher Medicine, a pioneering company in precision immunology and network medicine, has officially announced…
Altasciences Earns EcoVadis Gold Medal in Recognition of ESG Excellence
Altasciences Earns EcoVadis Gold Medal for ESG Excellence, Placing Among Top 5% of Global Companies Altasciences, a leading contract research organization (CRO) dedicated to providing comprehensive drug development solutions for…
Nucleus RadioPharma Names Former FDA Chief Dr. Stephen Hahn as CEO
Nucleus RadioPharma Appoints Former FDA Commissioner Dr. Stephen Hahn as CEO to Lead the Next Era of Radiopharmaceutical Innovation Nucleus RadioPharma, a next-generation contract development and manufacturing organization (CDMO) focused…
Rocket Pharmaceuticals Cleared to Resume Phase 2 RP-A501 Study in Danon Disease
Rocket Pharmaceuticals Announces FDA Lifts Clinical Hold on Pivotal Phase 2 Trial of RP-A501 in Danon Disease Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a…
MedImpact Launches Low-Cost Ustekinumab-aekn Biosimilar Nationwide
MedImpact Unveils Affordable Access to Unbranded Ustekinumab-aekn Biosimilar, Reshaping Specialty Pharmacy Market MedImpact Holdings Inc., the nation’s largest independent pharmacy benefit and healthcare solutions provider, announced a major step toward…
PharmaCyte Biotech Secures $7 Million in Funding from Existing Investors
PharmaCyte Biotech Strengthens Financial Position with $7 Million Private Placement Led by Existing Investors Financing provides strategic capital infusion to support corporate initiatives, enhance balance sheet, and advance long-term value…
IntegriChain Strengthens Leadership to Accelerate Innovation and Customer-Centric Growth
IntegriChain Appoints New Chief AI and Technology Officer to Lead Next Era of Innovation, Automation, and Customer Experience in Life Sciences IntegriChain, a recognized market leader in net revenue optimization…
jCyte Begins Patient Treatment in Phase JC02-88 Clinical Trial for Retinitis Pigmentosa
jCyte Marks Major Milestone with First Patients Treated in JC02-88 Clinical Trial Evaluating jCell for Retinitis Pigmentosa jCyte, Inc., a clinical-stage biotechnology company pioneering cell-based therapies for retinal diseases, announced…
ConcertAI Names Michael Myshrall as New Chief Financial Officer
ConcertAI Appoints Michael Myshrall as Chief Financial Officer, Strengthening Financial Leadership to Drive Growth in AI-Powered Healthcare and Life Sciences ConcertAI, a global leader in oncology generative and agentic artificial…
Ifinatamab Deruxtecan Receives FDA Breakthrough Therapy Designation in SCLC
Ifinatamab Deruxtecan Receives Breakthrough Therapy Designation from FDA for Pretreated Extensive-Stage Small Cell Lung Cancer The oncology research landscape took a significant step forward this week with the announcement that…